Department of Pharmacology and Systems Biology Center New York, Mount Sinai School of Medicine, New York, NY, USA.
Wiley Interdiscip Rev Syst Biol Med. 2011 Mar-Apr;3(2):129-35. doi: 10.1002/wsbm.114. Epub 2010 Aug 27.
Systems pharmacology involves the application of systems biology approaches, combining large-scale experimental studies with computational analyses, to the study of drugs, drug targets, and drug effects. Many of these initial studies have focused on identifying new drug targets, new uses of known drugs, and systems-level properties of existing drugs. This review focuses on systems pharmacology studies that aim to better understand drug side effects and adverse events. By studying the drugs in the context of cellular networks, these studies provide insights into adverse events caused by off-targets of drugs as well as adverse events-mediated complex network responses. This allows rapid identification of biomarkers for side effect susceptibility. In this way, systems pharmacology will lead to not only newer and more effective therapies, but safer medications with fewer side effects.
系统药理学涉及系统生物学方法的应用,将大规模的实验研究与计算分析相结合,用于研究药物、药物靶点和药物作用。这些初始研究中的许多都集中在确定新的药物靶点、已知药物的新用途以及现有药物的系统水平特性上。本综述重点介绍了旨在更好地了解药物副作用和不良事件的系统药理学研究。通过在细胞网络的背景下研究药物,这些研究深入了解了药物的非靶点引起的副作用以及副作用介导的复杂网络反应。这使得能够快速识别副作用易感性的生物标志物。通过这种方式,系统药理学不仅将带来更新、更有效的治疗方法,而且还将带来副作用更少、更安全的药物。